Quality of life with nivolumab and AVD first‐line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial
HemaSphere · 2026-10 · 10 (10)
DOI: 10.1002/hem3.70485 ↗Kurz gefasst
Fachartikel in der Zeitschrift HemaSphere, online erschienen am 29.09.2026. Verfasst von Christian Peter Jaworek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duessel…. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) University of Cologne Cologne Germany.
- German Hodgkin Study Group (GHSG) Cologne Germany.
- Department of Internal Medicine III TUM University Hospital, Technical University of Munich, School of Medicine and Health Munich Germany.
- Medicine V University of Heidelberg Heidelberg Germany.
- University Hospital Carl Gustav Carus Technische Universität Dresden Dresden Germany.
- Department of Oncology Universitätsklinikum Frankfurt, Johann Wolfgang Goethe‑Universität Frankfurt am Main Frankfurt am Main Germany.
ORCID-Profile: Christian Peter Jaworek, Karolin Trautmann-Grill, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Paul Jan Bröckelmann
Zitieren
APA
Jaworek, C. P., Bühnen, I., Herhaus, P., Meissner, J., Trautmann-Grill, K., Halbsguth, T., Kerkhoff, A., Schaub, V., Fuchs, M., von Tresckow, B., Borchmann, P., Behringer, K., & Bröckelmann, P. J. (2026). Quality of life with nivolumab and AVD first‐line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial. HemaSphere, 10(10). https://doi.org/10.1002/hem3.70485
Vancouver
Jaworek CP, Bühnen I, Herhaus P, Meissner J, Trautmann-Grill K, Halbsguth T, et al. Quality of life with nivolumab and AVD first‐line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial. HemaSphere. 2026;10(10). doi:10.1002/hem3.70485
BibTeX
@article{Jaworek2026,
author = {Jaworek, Christian Peter and Bühnen, Ina and Herhaus, Peter and Meissner, Julia and Trautmann-Grill, Karolin and Halbsguth, Teresa and Kerkhoff, Andrea and Schaub, Valdete and Fuchs, Michael and von Tresckow, Bastian and Borchmann, Peter and Behringer, Karolin and Bröckelmann, Paul Jan},
title = {Quality of life with nivolumab and AVD first‐line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {10},
doi = {10.1002/hem3.70485}
}
EUVIMED